Successfully Treated Hepatitis B Positive Refractory Myasthenic Crisis with Rituximab
Author:
Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Link
https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-23320
Reference8 articles.
1. 1. Jaretzki III A, Barohn RB, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards: task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 2000;55(1):16–23. DOI: 10.1212/WNL.55.1.16.
2. 2. Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 2016;87(4):419–425. DOI: 10.1212/WNL.0000000000002790.
3. 3. Panda S, Goyal V, Behari M, Singh S, Srivastava T. Myasthenic crisis: a retrospective study. Neurol India 2004;52(4): 453–456.
4. 4. Sharma S, Lal V, Prabhakar S, Agarwal R. Clinical profile and outcome of myasthenic crisis in a tertiary care hospital: a prospective study. Ann Indian Acad Neurol 2013;16(2):203–207. DOI: 10.4103/0972-2327.112466.
5. 5. Rahul LY, Dakua T, Mukherjee A. Refractory myasthenia gravis treated successfully with rituximab: a case report. Ann Indian Acad Neurol 2017;20(4):436–437. DOI: 10.4103/aian.AIAN_233_17.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry;Liver International;2024-05-29
2. Myasthenic crisis;Muscle & Nerve;2023-04-28
3. Clinical spectrum of myasthenia gravis: An institute experience over 8 years from North East India;Journal of Family Medicine and Primary Care;2022
4. Immune-globulin/rituximab/tenofovir;Reactions Weekly;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3